← Back to directory

Cynthia J. Tifft

Researcher Next ID · RN-022476

Researcher · Medicine

National Institutes of Health

Bethesda, Argentina

Not currently recruitingFunding unknown
Works count
320
Citation count
12,562
H-index
55
i10-index
152

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Lysosomal Storage Disorders Research
Genomics and Rare Diseases
Glycosylation and Glycoproteins Research
Cellular transport and secretion
Genetics and Neurodevelopmental Disorders

Publications

  • De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome

    Nature · 2024 · https://doi.org/10.1038/s41586-024-07773-7

  • Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies

    Journal of Clinical Investigation · 2023 · 10.1172/jci173510

  • AAV gene therapy for Tay-Sachs disease

    Nature Medicine · 2022 · 10.1038/s41591-021-01664-4

  • Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

    Journal of Clinical Investigation · 2019 · https://doi.org/10.1172/jci129301

  • Lysosomal storage diseases

    Nature Reviews Disease Primers · 2018 · https://doi.org/10.1038/s41572-018-0025-4

  • Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1714458

  • The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

    The American Journal of Human Genetics · 2017 · https://doi.org/10.1016/j.ajhg.2017.01.006

  • The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine

    Molecular Genetics and Metabolism · 2016 · 10.1016/j.ymgme.2016.01.007

  • The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy.

    PubMed · 2016

  • GRIN2A mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine

    Annals of Clinical and Translational Neurology · 2014 · 10.1002/acn3.39

  • Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia

    Human Molecular Genetics · 2013 · 10.1093/hmg/ddt429

  • Detecting false-positive signals in exome sequencing

    Human Mutation · 2012 · 10.1002/humu.22033

  • The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases

    Genetics in Medicine · 2012 · 10.1038/gim.0b013e318232a005

  • Natural History of Infantile GM2 Gangliosidosis

    PEDIATRICS · 2011 · 10.1542/peds.2011-0078

  • Whole-Exome Sequencing Identifies Homozygous AFG3L2 Mutations in a Spastic Ataxia-Neuropathy Syndrome Linked to Mitochondrial m-AAA Proteases

    PLoS Genetics · 2011 · 10.1371/journal.pgen.1002325

  • GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings

    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2011 · 10.1016/j.bbadis.2011.03.018

  • Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta

    Nature Genetics · 2007 · 10.1038/ng1968

  • Pompe disease diagnosis and management guideline

    Genetics in Medicine · 2006 · 10.1097/01.gim.0000218152.87434.f3

  • Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR

    Nature Genetics · 2004 · https://doi.org/10.1038/ng1321

  • Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation

    Proceedings of the National Academy of Sciences · 2000 · 10.1073/pnas.97.20.10954

  • Mice lacking both subunits of lysosomal β–hexosaminidase display gangliosidosis and mucopolysaccharidosis

    Nature Genetics · 1996 · 10.1038/ng1196-348

Current projects

    No projects listed.